The protective effect of Echinacea spp. (Echinacea angustifolia and Echinacea purpurea) in a rat colitis model induced by acetic acid

Pakistan Journal of Pharmaceutical Sciences

Volumn 27, Issue 6, 2014, Pages 1827-1835

  Dogan, Zeynal ^a   Ergul, Bilal ^a   Sarikaya, Murat ^a   Filik, Levent ^a   Gonultaş, Mehmet Alparslan ^a   Hucumenoglu, Sema ^a   Can, Murat ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

Author keywords

Echinacea spp.; IL 1 ; TGF ; TNF ; Ulcerative colitis

Indexed keywords

ACETIC ACID; ECHINACEA EXTRACT; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; PLANT EXTRACT; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DRUG EFFECT; ECHINACEA ANGUSTIFOLIA; HISTOPATHOLOGY; MALE; NONHUMAN; RAT; ULCERATIVE COLITIS; ANIMAL; COLITIS, ULCERATIVE; DISEASE MODEL; ECHINACEA; IMMUNOLOGY; PATHOLOGY; PHYTOTHERAPY;

ACETIC ACID; ANIMALS; COLITIS, ULCERATIVE; DISEASE MODELS, ANIMAL; ECHINACEA; INTERLEUKIN-1BETA; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PROTECTIVE AGENTS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908894659     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Andoh A, Yagi Y, Shioya M, Nishida A, Tsujikawa T and Fujiyama Y (2008). Mucosal cytokine network in inflammatory bowel disease. World J. Gastroenterol., 33: 5154-5161.
2. Appleyard CB and Wallace JL (1995). Reactivation of hapten induced colitis and its prevention by anti-inflammatory drugs. Am. J. Physiol., 269: 119-125.
3. Ardizzone S and Porro GB (2005). Biologic therapy for inflammatory bowel disease. Drugs., 65: 2253-2286.
4. Autenrieth I, Bucheler N, Bohn E, Heinze G and Horak I (1997). Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut., 41: 793-800.
5. Bauer C, Duewell P, Lehr HA, Endres S and Schnurr M (2012). Protective and aggravating effects of NIrp3 inflammasome activation in IBD models: Influence of genetic and environmental factors. Dig Dis., 30: 82-90.
6. Behera JP, Mohanty B, Ramani YR, Rath B and Pradhan S (2012). Effect of aqueous extract of Aegle marmelos unripe fruit on inflammatroy bowel disease. Indian J. Pharmacol., 44: 614-618.
7. Borchers AT, Keen CL, Stern JS and Gershwin ME (2000). ̄nflammation and Native American medicine: The role of botanicals. Am. J. Clin. Nutr., 72: 339-347.
8. Ebert EC, Panja A, Das KM, Praveen R, Geng X, Rezac C and Bajpai M (2009). Patients with inflammatory bowel disease may have a transforming growth factor-β, iterleukin (IL)-2 or IL-10 deficient state induced by intrinsic neutralizing antibodies. Clin. Exp. Immunol., 155: 65-71.
9. Fabia R, Willen R, ArRajab A, Andersson R, Ahren B and Bengmark S (1992). Acetic acid-induced colitis in the rat: A reproducible experimental model for acute ulcerative colitis. Eur. Surg. Res., 24: 211-225.
10. Ferkolj I (2009). How to improve the safety of biologic therapy in Crohn's disease. J. Physiol. Pharmacol., 60: 67-70.
11. Fiocchi C (1998). Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterolog., 115: 182-205.
12. Ha C and Dassopoulos T (2010). Thiopurine therapy in inflammatory bowel disease. Expert. Rev. Gastroenterol. Hepatol., 4: 575-588.
13. Hawinkels LJ, Verspaget HW, van Duijn W, van der Zon JM, Zuidwijk K, Kubben FJ, Verheijen JH, Hommes DW, Lamers CB and Sier CF (2007). Tissue level, activation and cellular localisation of TGF-b1 and association with survival in gastric cancer patients. British Journal of Cancer., 97: 398-404.
14. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS and Strober W (2002). Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity., 17: 629-638.
15. Kawada M, Arihiro A and Mizoguchi E (2007). Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J. Gastroenterol., 13: 5581-5593.
16. Linde K, Barrett B, Wölkart K, Bauer R and Melchart D (2006). Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev., 25: 1
17. Lowry OH, Rosebrough NJ, Farr A and Randall RJ (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265-275.
18. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR and Wallace JL (1989). Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology., 96: 795-803.
19. Ogata H and Hibi T (2003). Cytokine and anti-cytokine therapies for inflammatory bowel disease. Current Pharmaceutical Design., 14: 1107-1113.
20. Papadakis KA and Targan SR (2000). Role of cytokines in the pathogenesis of inflammatory bowel disease. Annual Review of Medicine, 51: 289-298.
21. Peltz C, Jordan K and Boes TJ (2012). Infliximab-induced nonspesific interstital pneumonia. Sen. S., 344: 75-78.
22. Pleschka S, Stein M, Schoop R and Hudson JB (2009). Antiviral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian Influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J., 6: 197-206.
23. Reddy JG and Loftus Jr EV (2006). Safety of infliximab and other biologic agents in the inflammatory bowel diseases. Gastroenterology Clinics of North America, 35: 837-855.
24. Rogler G and Andus T (1998). Cytokines in inflammatory bowel disease. World Journal of Surgery, 22: 382-389.
25. Sharma M, Anderson SA, Schoop R and Hudson JB (2009). Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Research., 83: 165-170.
26. Strober W, Fuss IJ and Blumberg RS (2002). The immunology of mocosal models of inflammation. Annu. Rev. Immunol., 20: 495-549.
27. Standnyk AW, Dollard C, Issekutz TB and Issekutz AC (2002). Neutrophil migration into indomethacin induced rat small intestinal injury is CD11a/CD18 and CD11b/CD18 co-dependent. Gut, 50: 629-635.
28. Thomas P (2001). Echinacea: A natural remedy for the common cold and flu? Nutr Today., 36: 249-253.
29. Zhai Z, Haney DM, Wu L, Solco AK, Murphy PA, Wurtele ES, Kohut MI and Cunnick JE (2009). Alcohol extract of Echinacea pallida reverses stress-delayed wound healing in mice. Phytomedicine, 16: 669-678.